SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106. A total of 99 filers reported holding SILVER STD RES INC in Q2 2013. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $183,014,000 | -37.0% | 19,539 | -28.8% | 0.00% | 0.0% |
Q1 2017 | $290,597,000 | -33.8% | 27,457 | -41.2% | 0.00% | -50.0% |
Q4 2016 | $439,139,000 | +629.0% | 46,686 | +834.7% | 0.00% | – |
Q3 2016 | $60,240,000 | -4.6% | 4,995 | -56.1% | 0.00% | – |
Q1 2016 | $63,137,000 | -50.9% | 11,376 | -54.2% | 0.00% | – |
Q4 2015 | $128,620,000 | +142.7% | 24,830 | +205.4% | 0.00% | – |
Q3 2015 | $53,001,000 | -71.3% | 8,129 | -69.4% | 0.00% | – |
Q4 2013 | $184,732,000 | -99.9% | 26,542 | -98.4% | 0.00% | -100.0% |
Q3 2013 | $124,059,666,000 | -56.0% | 1,668,157 | -55.5% | 0.09% | -54.8% |
Q2 2013 | $281,962,000,000 | – | 3,750,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syntal Capital Partners, LLC | 17,540 | $167,000 | 0.12% |